Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bahil Ghanim

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
The European Respiratory Journal|April 27, 2019
Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertensionRita Papp, Chandran Nagaraj, Diana Zabini, et al.
Cancers|July 27, 2024
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective StudyMaximilian Hochmair, Angelika Terbuch, David Lang, et al.
American Journal of Respiratory and Critical Care Medicine|September 5, 2014
Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapyKarin Schelch, Mir A Hoda, Thomas Klikovits, et al.
The Journal of Pathology|May 27, 2015
Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesotheliomaViktoria Laszlo, Mir Alireza Hoda, Tamas Garay, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2016
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional studyMir Alireza Hoda, Yawen Dong, Anita Rozsas, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
The European Respiratory Journal|April 27, 2019
Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertensionRita Papp, Chandran Nagaraj, Diana Zabini, et al.
Cancers|July 27, 2024
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective StudyMaximilian Hochmair, Angelika Terbuch, David Lang, et al.
American Journal of Respiratory and Critical Care Medicine|September 5, 2014
Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapyKarin Schelch, Mir A Hoda, Thomas Klikovits, et al.
The Journal of Pathology|May 27, 2015
Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesotheliomaViktoria Laszlo, Mir Alireza Hoda, Tamas Garay, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2016
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional studyMir Alireza Hoda, Yawen Dong, Anita Rozsas, et al.
Pageof 6